Comparison of phenotypic tests for detecting BKC-1–producing Enterobacteriaceae isolates  by Martins, Willames M.B.S. et al.
Diagnostic Microbiology and Infectious Disease 84 (2016) 246–248
Contents lists available at ScienceDirect
Diagnostic Microbiology and Infectious Disease
j ourna l homepage: www.e lsev ie r .com/ locate /d iagmicrob ioComparison of phenotypic tests for detecting BKC-1–producing
Enterobacteriaceae isolatesWillames M.B.S. Martins ⁎, Jhonatha R. Cordeiro-Moura, Ana C. Ramos, Lorena C. Fehlberg,
Adriana G. Nicoletti, Ana C. Gales
Laboratório Alerta, Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina/Universidade Federal de São Paulo, São Paulo, Brazil
a b s t r a c ta r t i c l e i n f o⁎ Corresponding author. Tel./fax: +55-1155764748.
E-mail address: willamesbrasileiro@hotmail.com (W.M
http://dx.doi.org/10.1016/j.diagmicrobio.2015.11.021
0732-8893/© 2016 Elsevier Inc. All rights reserved.Article history:
Received 12 September 2015
Received in revised form 18 November 2015
Accepted 25 November 2015
Available online 27 November 2015
Keywords:
Carbapenemase
BKC-1
Klebsiella pneumoniae
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producing weak carbapenemases. Routine clinical laboratories have employed phenotypic tests for screening such
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important health public problem in many geographic regions including
Latin America. To date, several mechanisms of carbapenem resistance
have been described including production of beta-lactamases, porin loss,
penicillin-binding protein alteration, and/or overexpression of efﬂux sys-
tems (Gupta et al., 2011). The production of carbapenemases represents
themost importantmechanismof carbapenem resistance in Enterobacte-
riaceae. The last decade was marked by the emergence and spread of
carbapenemases like KPC-, NDM-, or OXA-48 among Enterobacteriaceae
isolated worldwide (Nordmann and Poirel, 2013).
Unfortunately, carbapenemase-producing Enterobacteriaceae iso-
lates may show low imipenem and/or meropenem MICs, being
miscategorized as susceptible to carbapenems, especially by automated
susceptibility testing systems. In this manner, routine microbiological
laboratories must rely on phenotypic tests for accurate detection of
carbapenemase producers. Modiﬁed Hodge Test (MHT), combined
disk, and double-disk synergy test (DDST)were phenotypic testswidely
employed for carbapenemase detection (Hammoudi et al., 2014). Al-
though these tests are easy, simple, and widely available, they are not
rapid and reliable. MHT has shown low sensitivity and speciﬁcity rates
failing to detect NDM-1- (false negatives), ESBL, and/or AmpC-
producing Enterobacteriaceae (false positives) (Carvalhaes et al.,
2010). In this manner, CarbaNP, Blue-Carba, and Carbapenembac™
(Probac Brazil) have been employed for rapid detection of
carbapenemase-producing Gram-negative bacilli (Martino et al., 2015;Nordmann et al., 2012; Pires et al., 2013). Detection of carbapenem hy-
drolysis by matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry (MALDI TOF MS) has also been successfully used
for detection of carbapenemase activity (Carvalhaes et al., 2013).
Recently, a new carbapenemase encoding gene, blaBKC-1, was de-
scribed in Klebsiella pneumoniae clinical isolated from Southeast Brazil.
BKC-1 is a weak serine class A carbapenemase that interestingly
shows higher hydrolytic activity towards oxacillins (Nicoletti et al.,
2015). In this study, we aimed to evaluate the behavior of distinct phe-
notypic methods against BKC-1–producing Enterobacteriaceae.
Six isolates previously characterized as BKC-1 producers (5
K. pneumoniae clinical isolates and 1 Escherichia coli DH5α harboring
p10Kb with blaBKC-1, named T3) were selected for this study (Table 1).
We compared the results of 9 different phenotypic methods: MHT,
phenylboronic acid/disk combination (AFB/DC), EDTA/disk combination
(EDTA/DC), cloxacillin/disk combination (Cloxa/DC) (ANVISA, 2013;
CLSI, 2015b), imipenem hydrolysis testes by spectrophotometry (Picão
et al., 2008), ertapenem hydrolysis by MALDI-TOF MS (Bruker Daltonic,
Bremen, Germany) (Carvalhaes et al., 2013), CarbaNP Test (Nordmann
et al., 2012), Blue-Carba (Pasteran et al., 2015; Pires et al., 2013), and
Carbapenembac™ Test (Martino et al., 2015). The tests were carried out
as previously described. NDM-1–producing K. pneumoniae ATCC BAA-
2146, KPC-2–producing K. pneumoniae Kp13, and OXA-72–producing
Acinetobacter baumannii A30235 were tested as positive quality controls
(QC), while K. pneumoniaeATCC 700603was tested as negative QC. Addi-
tionally, we performed the antimicrobial susceptibility testing to carba-
penems by disk diffusion and broth microdilution methodologies
according CLSI guideline (CLSI, 2015b). The results were interpreted fol-
lowing CLSI recommendations (CLSI, 2015a).
Table 1
Molecular and phenotypic characteristics of BKC-1–producing isolates.
Isolates Bacteria species β-Lactam
resistance genes
MIC (μg/mL) Disk diffusion (mm) AFB/DC (mm) EDTA/DC (mm)
ETP IPM MEM ETP IPM MEM IPM + AFB MEM + AFB IMP + EDTA MEM + EDTA
KP60134 K. pneumoniae blaCTX-M-2;
blaSHV-110-like; blaBKC-1
64 [R] 8 [R] 16 [R] 11 [R] 20 [I] 18 [R] 21 [Neg.] 20 [Neg.] 22 [Neg.] 19 [Neg.]
KP60135 K. pneumoniae blaCTX-M-2;
blaSHV-110-like; blaBKC-1
64 [R] 4 [R] 8 [R] 14 [R] 23 [S] 20 [I] 23 [Neg.] 22 [Neg.] 24 [Neg.] 21 [Neg.]
KP60136 K. pneumoniae blaCTX-M-2;
blaSHV-110-like; blaBKC-1
N256 [R] 128 [R] 32 [R] 13 [R] 7 [R] 6 [R] 14 [Pos.] 19 [Pos.] 12 [Pos.] 16 [Pos.]
KP68324 K. pneumoniae blaCTX-M-2;
blaSHV-110-like; blaBKC-1
32 [R] 32 [R] 8 [R] 12 [R] 20 [I] 21 [I] 23 [Neg.] 20 [Neg.] 22 [Neg.] 19 [Neg.]
KP69725 K. pneumoniae blaSHV-110-like; blaBKC-1 64 [R] 32 [R] 32 [R] 7 [R] 15 [R] 13 [R] 18 [Neg.] 16 [Neg.] 19 [Neg.] 15 [Neg.]
T3 isolate E. coli blaBKC-1 64 [R] 8 [R] 8 [R] 12 [R] 18 [R] 19 [R] 20 [Neg.] 23 [Neg.] 18 [Neg.] 19 [Neg.]
KP13 (KPC + QC) K. pneumoniae blaKPC-2;
blaCTX-M-2,
blaSHV-11, blaOXA-9
NT NT NT 6 [R] 6 [R] 6 [R] 22 [Pos.] 19 [Pos.] 15 [Pos.] 10 [Neg.]
KP ATCC BAA-2146
(NDM + QC)
K. pneumoniae blaNDM-1 NT NT NT 6 [R] 10 [R] 6 [R] 9 [Neg.] 8 [Neg.] 31 [Pos.] 30 [Pos.]
ACB 30235
(OXA-72 + QC)
A. baumannii blaOXA-72;
blaOXA-51
NT NT NT 6 [R] 12 [R] 6 [R] 16 [Neg.] 8 [Neg.] 14 [Neg.] 15 [Pos.]
ETP = ertapenem; IPM = imipenem; MEM = meropenem; NT = no tested; [R] = resistant; [S] = susceptible; [Neg.] = negative; [Pos.] = positive.
Fig. 1.Distinctmethodologies applied for screening BKC-1–producing Enterobacteriaceae. (A) Pattern of ertapenemhydrolysis (0.25mg/mL) byMALDI-TOF. I, negative control; II, positive
control; III, IV, and V, common proﬁle of hydrolysis pattern showed by BKC-1–producing K. pneumoniae isolates after 15, 60, and 120 minutes of incubation; VI, VII, and VIII, proﬁle of T3
after 15, 60, and 120 minutes of incubation. (B) Pattern of imipenem hydrolysis (3 mg/mL) by spectrophotometry after 8 minutes of incubation. I, K. pneumoniae ATCC 700603 (negative
QC); II, K. pneumoniae KP13 (positive QC)—incubation of imipenem with KPC-2–producing strain; III, common proﬁle of hydrolysis pattern showed by BKC-1–producing K. pneumoniae
isolates; IV, proﬁle of T3 isolate. (C) Carbapenembac™ tests. Columns I–IV, 15, 30, 60, and 120 minutes of incubation, respectively. Line 1, K. pneumoniae ATCC 700603 (negative QC);
line 2, K. pneumoniae KP13 (positive QC); line 3, KP60136; line 4, KP60135; line 5, KP60134; line 6, KP68324; line 7, KP69725; and, line 8, T3. (D) CarbaNP Test. Lines I–III, 30, 60, and
120 minutes of incubation, respectively. Line 1, KP60136; line 2, KP60135; line 3, KP60134; line 4, KP68324; line 5, KP69725; line 6, T3, line 7, only Carba-NP solution; line 8,
K. pneumoniae ATCC 700603 (negative QC); and line 9, K. pneumoniae KP13 (positive QC). (E) MHT. 1, KP60136; 2, KP60135; 3, KP60134; 4, KP68324; 5, KP69725; 6, T3; C+,
K. pneumoniae KP13 (positive QC); and, C−, K. pneumoniae ATCC 700603 (negative QC). (F) Blue-Carba. Lines I–III, 15, 30, and 60 minutes of incubation, respectively. Column 1,
KP60136; column 2, KP60135; column 3, KP60134; column 4, KP68324; column 5, T3 isolate; column 6, KP69725; column 7, K. pneumoniae KP13 (positive QC); and column 8,
K. pneumoniae ATCC 700603 (negative QC).
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except for T3 isolate (positive) and KP68324 (weak positive) (Fig. 1).
However, when we replaced the ertapenem by the meropenem disk,
some BKC-producing isolates showed a weak positive result. These re-
sults could be attributed to the BKC-1 poor hydrolytic activity against
ertapenem when compared to that of meropenem (Nicoletti et al.,
2015). Weak positive results are difﬁcult to interpret because they de-
pend on the reader's expertise. Previous studies also have shown that
MHT is a reliable test to detect KPC and OXA-48 but fail in identify
MβL and cabapenemases with poor hydrolytic activity (Doyle et al.,
2012; Hrábak et al., 2014). Three BKC-1–producing isolates showed car-
bapenem inhibition zones within the susceptibility or intermediate
breakpoint ranges and could not have been recognized by routine mi-
crobiology clinical laboratories using disk diffusion. A single BKC-1–pro-
ducing isolate, KP60136, was detected as carbapenemase producer by
AFB/DC. Nonetheless, we also veriﬁed EDTA/DC false-positive result
for this isolate. K. pneumoniae isolates exhibiting porin loss (OmpK35
and/or OmpK36) maybe falsely recognized as carbapenemase pro-
ducers (Cassu-Corsi et al., 2015). We did not verify false-positive tests
with Cloxa/DC test against BKC-1 producers.
BKC-1–producing isolates were detected as carbapenemase pro-
ducers by both spectrophotometry and MALDI-TOF MS. However, an
extended period of incubation was necessary for detection of BKC-1
carbapenemase activity by both methodologies, spectrophotometry (8
versus 3 minutes for NDM and KPC QC controls) and MALDI-TOF MS
(2–4 hours versus 15 minutes NDM and KPC QC controls, except for
the T3 isolate, thatwas detected after 15-minute incubation; Fig. 1). Dif-
ferent results observed for T3 strain could be attributed to a higher ex-
pression of blaBKC-1 in a distinct host. Interestingly, a characteristic
hydrolysis curve was observed for BKC-1–producing isolates on the
spectrophotometer (Fig. 1).
CarbaNP Test, Blue-Carba, and Carbapenembac™ are relatively new
tests that have been employed for rapid identiﬁcation of
carbapenemase producers. These tests are based on the reduction of
pH due to beta-lactam ring hydrolysis by carbapenemase. Due to its
high sensitivity and speciﬁcity, CarbaNP has been recommended by
CLSI for phenotypic detection of carbapenemase-producing Enterobac-
teriaceae (CLSI, 2015a). In our study, CarbaNP showed positive results
only after 2-hour incubation period (Fig. 1). In contrast, Blue-Carba
was faster than Carba-NP to identify BKC-1–producing isolates,
resulting in positive results after 15 minutes of incubation.
Carbapenembac™ is a test developed by Probac, Brazil, for detection of
carbapenemases, mainly KPC (Martino et al., 2015). Carbapenembac™
consists of a strip that is impregnated with a concentration of 100 μg
imipenem and starch, and which shows distinct end staining after bac-
teria incubation (change of dark becoming clear) due to carbapenemase
activity (Martino et al., 2015). The presence of BKC-1 was detected by
this methodology; however, different to what was previously observed
byMartino et al. (2015), who tested only KPC-producing Enterobacteri-
aceae, our results showed that the test reading was easier after 3 hours
of incubation to identify BKC-1–producing isolates.
BKC-1 encoding gene was reported only in Enterobacteriaceae iso-
lated from the city of São Paulo, but we believe that this enzyme
might be encountered in other Enterobacteriaceae species or geograph-
ic regions since this gene has been associatedwith ISKpn23, an insertion
sequence reported for the ﬁrst time in K. pneumoniae, but commonly
found among soil bacteria (Nicoletti et al., 2015). Poor hydrolytic activ-
ity of BKC-1 against carbapenems seems to be the main cause of MHT
and AFB/DC negative results. This fact consists the principal challenge
to clinical routine laboratories in screening BKC-1 producers. The differ-
ence on carbapenems MICs observed could be attributed to thepresence of additional mechanisms of beta-lactam resistance detected
in these isolates (Nicoletti et al., 2015). The identiﬁcation of blaBKC by
molecular tests is the gold standard methodology for conﬁrming its
presence. However, adequate phenotypic tests are of fundamental im-
portance for accurately screening BKC-1–producing isolates. Although
a few number of isolates were tested in our study, due to the paucity
of BKC-1–producing isolates described so far, our results showed that
rapid tests, Carba-NP, Blue-Carba, and Carbapenembac™ were reliable
for phenotypic detection of BKC production.
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